AMIT KUMAR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for AMIT KUMAR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AMIT KUMAR. AMIT KUMAR is an Chief Executive Officer in ITUS Corp ($COPY) and a Director in ITUS Corp ($COPY) and a Pres/CEO of CombiMatrix Corp. in ACACIA RESEARCH CORP ($ACTG/CBMX) and a Director in AEOLUS PHARMACEUTICALS, INC. ($INCR.OB) and a Director in Ascent Solar Technologies, Inc. ($ASTI).
Address: 500 NEWPORT CENTER DRIVE 7TH FLOOR NEWPORT BEACH 92660 CA
Companies in which AMIT KUMAR is an Insider
ACACIA RESEARCH CORP
Industry: PATENT OWNERS & LESSORS [6794]
Position of AMIT KUMAR: Pres/CEO of CombiMatrix Corp.
Holdings: 328,614 shares
Latest Transaction: May 08 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AEOLUS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of AMIT KUMAR: Director
Holdings: 0 shares
Latest Transaction: Feb 03 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Anixa Biosciences Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of AMIT KUMAR: Chief Executive Officer, Director
Holdings: 272,000 shares
Latest Transaction: Feb 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ascent Solar Technologies, Inc.
Industry: SEMICONDUCTORS & RELATED DEVICES [3674]
Position of AMIT KUMAR: Director
Holdings: 934,970 shares
Current Value: $0
Latest Transaction: May 23 2016
$ASTI Market Capitalization: $558828.38
$ASTI Previous Close: $0.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of AMIT KUMAR
Sentiment: All, ACTG/CBMX, INCR.OB, COPY, ASTI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 3.73 | 10,000 | 37,300 | 272,000 | 262 K to 272 K (+3.82 %) |
| Dec 28 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 2.83 | 1,000,000 | 2,830,000 | 1,000,000 | |
| Sep 11 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 2.11 | 28,000 | 59,080 | 262,000 | 234 K to 262 K (+11.97 %) |
| Jun 12 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 2.03 | 20,000 | 40,600 | 234,000 | 214 K to 234 K (+9.35 %) |
| Mar 12 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 1.82 | 20,000 | 36,400 | 214,000 | 194 K to 214 K (+10.31 %) |
| Jan 14 2020 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Buy | P | 2.99 | 20,000 | 59,800 | 194,000 | 174 K to 194 K (+11.49 %) |
| Dec 16 2019 | COPY | Anixa Biosciences ... | KUMAR AMIT | Chief Executive Off ... | Option Exercise | A | 3.84 | 520,000 | 1,996,800 | 520,000 |